Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tai Guk Pharm is a prominent South Korean pharmaceutical company specializing in the development and manufacture of over-the-counter (OTC) and prescription topical medications. Established in 1957, the company has built a strong reputation for its expertise in external preparations, including ointments, creams, and gels, with its flagship product Domina Cream leading the domestic melasma treatment market. In 2017, the company was acquired by LG Chem, integrating its specialized production capabilities into LG's broader life sciences portfolio. Tai Guk Pharm operates one of the largest topical medicine manufacturing facilities in Korea, located in Buyeo, which adheres to EU-GMP standards. The company continues to expand its product line into health functional foods and dermo-cosmetics while maintaining a significant presence in the domestic retail pharmacy sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAI GUK PHARM.